$FG
F&G Annuities & Life, Inc. Stock $fg

$fg Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-Q Financial Statement

#000193485024000027 Filed on May 10, 2024

Income Statement

Concept	2024 Q2	2024 Q1	2023 Q1
Revenue	$1.172B	$1.569B	$869.0M
YoY Change	0.34%	80.55%	15.87%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$69.00M	$66.00M	$53.00M
YoY Change	23.21%	24.53%	76.67%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$147.0M	$123.0M	$90.00M
YoY Change	41.35%	36.67%	18.42%
% of Gross Profit
Operating Expenses	$913.0M	$1.397B	$991.0M
YoY Change	-9.6%	40.97%	203.06%
Operating Profit
YoY Change
Interest Expense	$28.00M	$30.00M	$22.00M
YoY Change	12.0%	36.36%	175.0%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	$254.0M	$142.0M	-$203.0M
YoY Change	55.83%	-169.95%	-158.84%
Income Tax	$50.00M	$26.00M	-$8.000M
% Of Pretax Income	19.69%	18.31%
Net Earnings	$203.0M	$115.0M	-$195.0M
YoY Change	56.15%	-158.97%	-181.59%
Net Earnings / Revenue	17.32%	7.33%	-22.44%
Basic Earnings Per Share	$1.60	$0.90	-$1.56
Diluted Earnings Per Share	$1.55	$0.88	-$1.56
COMMON SHARES
Basic Shares Outstanding	126.1M shares	126.3M shares	126.4M shares
Diluted Shares Outstanding	131.0M shares	130.0M shares	125.0M shares

Balance Sheet

Concept	2024 Q2	2024 Q1	2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents	$3.526B	$2.372B	$1.584B
Short-Term Investments
Other Short-Term Assets	$983.0M	$980.0M
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$983.0M	$980.0M	$8.721B
YoY Change	-89.21%	-88.76%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill	$2.017B	$2.017B	$1.749B
YoY Change	15.32%	15.32%
Intangibles			$3.677B
YoY Change
Long-Term Investments	$3.705B	$3.367B	$2.669B
YoY Change	32.18%	26.15%
Other Assets	$748.0M	$608.0M
YoY Change
Total Long-Term Assets	$77.53B	$73.45B	$50.69B
YoY Change	44.98%	44.9%
TOTAL ASSETS
Total Short-Term Assets	$983.0M	$980.0M	$8.721B
Total Long-Term Assets	$77.53B	$73.45B	$50.69B
Total Assets	$78.51B	$74.43B	$59.41B
YoY Change	25.44%	25.28%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$178.0M	$176.0M	$1.777B
YoY Change	-91.24%	-90.1%
Accrued Expenses	$1.817B	$1.760B
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$2.328B	$2.237B	$1.777B
YoY Change	14.57%	25.89%
LONG-TERM LIABILITIES
Long-Term Debt	$2.038B	$1.748B	$1.572B
YoY Change	29.73%	11.2%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$2.038B	$1.748B	$1.572B
YoY Change	29.73%	11.2%
TOTAL LIABILITIES
Total Short-Term Liabilities	$2.328B	$2.237B	$1.777B
Total Long-Term Liabilities	$2.038B	$1.748B	$1.572B
Total Liabilities	$74.72B	$70.75B	$56.93B
YoY Change	24.4%	24.28%
SHAREHOLDERS EQUITY
Retained Earnings	$2.182B	$2.011B	$1.866B
YoY Change	10.71%	7.77%
Common Stock	$3.449B	$3.442B	$3.167B
YoY Change	8.7%	8.68%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$24.00M	$24.00M	$0.00
YoY Change	50.0%
Treasury Stock Shares
Shareholders Equity	$3.654B	$3.546B	$2.485B
YoY Change
Total Liabilities & Shareholders Equity	$78.51B	$74.43B	$59.41B
YoY Change	25.44%	25.28%

Cashflow Statement

Concept	2024 Q2	2024 Q1	2023 Q1
OPERATING ACTIVITIES
Net Income	$203.0M	$115.0M	-$195.0M
YoY Change	56.15%	-158.97%	-181.59%
Depreciation, Depletion And Amortization	$147.0M	$123.0M	$90.00M
YoY Change	41.35%	36.67%	18.42%
Cash From Operating Activities	$1.055B	$1.534B	$1.437B
YoY Change	-23.55%	6.75%	239.72%
INVESTING ACTIVITIES
Capital Expenditures	$5.000M	$7.000M	$6.000M
YoY Change	-37.5%	16.67%	-45.45%
Acquisitions
YoY Change
Other Investing Activities	-$1.840B	-$1.377B	-$2.402B
YoY Change	0.55%	-42.67%	10.34%
Cash From Investing Activities	-$1.845B	-$1.384B	-$2.408B
YoY Change	0.38%	-42.52%	10.05%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	1.944B	$659.0M	$1.595B
YoY Change	245.91%	-58.68%	13.93%
NET CHANGE
Cash From Operating Activities	1.055B	$1.534B	$1.437B
Cash From Investing Activities	-1.845B	-$1.384B	-$2.408B
Cash From Financing Activities	1.944B	$659.0M	$1.595B
Net Change In Cash	1.154B	$809.0M	$624.0M
YoY Change	1009.62%	29.65%	-270.96%
FREE CASH FLOW
Cash From Operating Activities	$1.055B	$1.534B	$1.437B
Capital Expenditures	$5.000M	$7.000M	$6.000M
Free Cash Flow	$1.050B	$1.527B	$1.431B
YoY Change	-23.47%	6.71%	247.33%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q1	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	58000000	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	22000000	usd
CY2023Q1	fg	Benefits Losses And Expenses Net BenefitsLossesAndExpensesNet	1072000000	usd
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.56
CY2023Q1	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	36000000	usd
CY2024Q1	us-gaap	Net Investment Income NetInvestmentIncome	616000000	usd
CY2023Q1	us-gaap	Net Investment Income NetInvestmentIncome	519000000	usd
CY2024Q1	us-gaap	Gain Loss On Investments GainLossOnInvestments	212000000	usd
CY2024Q1	us-gaap	Revenues Revenues	1569000000	usd
CY2023Q1	us-gaap	Revenues Revenues	869000000	usd
CY2024Q1	fg	Policyholder Benefits And Claims Incurred Net Life And Annuity Remeasurement Gains Losses PolicyholderBenefitsAndClaimsIncurredNetLifeAndAnnuityRemeasurementGainsLosses	1161000000	usd
CY2023Q1	fg	Policyholder Benefits And Claims Incurred Net Life And Annuity Remeasurement Gains Losses PolicyholderBenefitsAndClaimsIncurredNetLifeAndAnnuityRemeasurementGainsLosses	812000000	usd
CY2023Q1	us-gaap	Market Risk Benefit Change In Fair Value Gain Loss MarketRiskBenefitChangeInFairValueGainLoss	-59000000	usd
CY2024Q1	us-gaap	Fair Value Recurring Basis Unobservable Input Reconciliation Asset Gain Loss Statement Of Income Extensible List FairValueRecurringBasisUnobservableInputReconciliationAssetGainLossStatementOfIncomeExtensibleList	http://fasb.org/us-gaap/2023#GainLossOnInvestments
CY2024Q1	us-gaap	Fair Value Recurring Basis Unobservable Input Reconciliation Liability Gain Loss Statement Of Income Extensible List FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList	http://fasb.org/us-gaap/2023#GainLossOnInvestments
CY2023Q1	us-gaap	Fair Value Recurring Basis Unobservable Input Reconciliation Asset Gain Loss Statement Of Income Extensible List FairValueRecurringBasisUnobservableInputReconciliationAssetGainLossStatementOfIncomeExtensibleList	http://fasb.org/us-gaap/2023#GainLossOnInvestments
CY2023Q1	us-gaap	Fair Value Recurring Basis Unobservable Input Reconciliation Liability Gain Loss Statement Of Income Extensible List FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList	http://fasb.org/us-gaap/2023#GainLossOnInvestments
CY2024Q1	us-gaap	Debt Securities Available For Sale Accrued Interest After Allowance For Credit Loss Statement Of Financial Position Extensible List DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLossStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#PrepaidExpenseAndOtherAssets
CY2023Q4	us-gaap	Debt Securities Available For Sale Accrued Interest After Allowance For Credit Loss Statement Of Financial Position Extensible List DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLossStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#PrepaidExpenseAndOtherAssets
CY2024Q1	us-gaap	Derivative Gain Loss Statement Of Income Or Comprehensive Income Extensible Enumeration DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration	http://fasb.org/us-gaap/2023#GainLossOnInvestments
CY2023Q1	us-gaap	Derivative Gain Loss Statement Of Income Or Comprehensive Income Extensible Enumeration DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration	http://fasb.org/us-gaap/2023#GainLossOnInvestments
CY2024Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	5000000	shares
CY2024Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	5000000	shares
CY2024Q1	us-gaap	Insurance Commissions And Fees InsuranceCommissionsAndFees	23000000	usd
CY2023Q1	us-gaap	Insurance Commissions And Fees InsuranceCommissionsAndFees	0	usd
CY2023Q1	us-gaap	Gain Loss On Investments GainLossOnInvestments	-15000000	usd
CY2024Q1	us-gaap	Market Risk Benefit Change In Fair Value Gain Loss MarketRiskBenefitChangeInFairValueGainLoss	11000000	usd
CY2024Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	123000000	usd
CY2023Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	90000000	usd
CY2024Q1	us-gaap	Labor And Related Expense LaborAndRelatedExpense	66000000	usd
CY2023Q1	us-gaap	Labor And Related Expense LaborAndRelatedExpense	53000000	usd
CY2024Q1	us-gaap	Interest Expense InterestExpense	30000000	usd
CY2024Q1	fg	Benefits Losses And Expenses Net BenefitsLossesAndExpensesNet	1427000000	usd
CY2024Q1	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	142000000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-203000000	usd
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	26000000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-8000000	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	116000000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-195000000	usd
CY2024Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	1000000	usd
CY2023Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	0	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	115000000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-195000000	usd
CY2024Q1	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	4000000	usd
CY2023Q1	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	0	usd
CY2024Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	111000000	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-195000000	usd
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.90
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.88
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.56
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	124000000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	125000000	shares
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	130000000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	125000000	shares
CY2024Q1	fg	Policyholder Benefits And Claims Incurred Net Remeasurement Gain Loss PolicyholderBenefitsAndClaimsIncurredNetRemeasurementGainLoss	7000000	usd
CY2023Q1	fg	Policyholder Benefits And Claims Incurred Net Remeasurement Gain Loss PolicyholderBenefitsAndClaimsIncurredNetRemeasurementGainLoss	-4000000	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	116000000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-195000000	usd
CY2024Q1	us-gaap	Oci Liability For Future Policy Benefit Gain Loss After Reclassification Adjustment And Tax OciLiabilityForFuturePolicyBenefitGainLossAfterReclassificationAdjustmentAndTax	91000000	usd
CY2023Q1	us-gaap	Oci Liability For Future Policy Benefit Gain Loss After Reclassification Adjustment And Tax OciLiabilityForFuturePolicyBenefitGainLossAfterReclassificationAdjustmentAndTax	-100000000	usd
CY2024Q1	us-gaap	Oci Market Risk Benefit Instrument Specific Credit Risk Gain Loss After Adjustments And Tax OciMarketRiskBenefitInstrumentSpecificCreditRiskGainLossAfterAdjustmentsAndTax	1000000	usd
CY2023Q1	us-gaap	Oci Market Risk Benefit Instrument Specific Credit Risk Gain Loss After Adjustments And Tax OciMarketRiskBenefitInstrumentSpecificCreditRiskGainLossAfterAdjustmentsAndTax	7000000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	2000000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	321000000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-2000000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	1000000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax	-15000000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax	-41000000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	107000000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	270000000	usd
CY2024Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	223000000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	75000000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest	1000000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest	0	usd
CY2024Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	222000000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	75000000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	2405000000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	5000000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	270000000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-195000000	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	2485000000	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	3103000000	usd
CY2024Q1	us-gaap	Noncontrolling Interest Increase From Business Combination NoncontrollingInterestIncreaseFromBusinessCombination	136000000	usd
CY2024Q1	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	6000000	usd
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	7000000	usd
CY2024Q1	us-gaap	Dividends Preferred Stock Cash DividendsPreferredStockCash	4000000	usd
CY2024Q1	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	26000000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	107000000	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	116000000	usd
CY2024Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	3683000000	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	116000000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-195000000	usd
CY2024Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	123000000	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	90000000	usd
CY2024Q1	fg	Gain Loss On Investments And Disposition Of Other Assets And Asset Impairments GainLossOnInvestmentsAndDispositionOfOtherAssetsAndAssetImpairments	-8000000	usd
CY2023Q1	fg	Gain Loss On Investments And Disposition Of Other Assets And Asset Impairments GainLossOnInvestmentsAndDispositionOfOtherAssetsAndAssetImpairments	-182000000	usd
CY2024Q1	fg	Increase Decrease Interest Credited To Policy Owner Account IncreaseDecreaseInterestCreditedToPolicyOwnerAccount	513000000	usd
CY2023Q1	fg	Increase Decrease Interest Credited To Policy Owner Account IncreaseDecreaseInterestCreditedToPolicyOwnerAccount	463000000	usd
CY2024Q1	us-gaap	Market Risk Benefit Change In Fair Value Gain Loss MarketRiskBenefitChangeInFairValueGainLoss	11000000	usd
CY2023Q1	us-gaap	Market Risk Benefit Change In Fair Value Gain Loss MarketRiskBenefitChangeInFairValueGainLoss	-59000000	usd
CY2024Q1	fg	Increase Decrease In Deferred Policy Acquisition Costs And Deferred Sales Inducements IncreaseDecreaseInDeferredPolicyAcquisitionCostsAndDeferredSalesInducements	311000000	usd
CY2023Q1	fg	Increase Decrease In Deferred Policy Acquisition Costs And Deferred Sales Inducements IncreaseDecreaseInDeferredPolicyAcquisitionCostsAndDeferredSalesInducements	251000000	usd
CY2024Q1	fg	Charges Assessed To Contract Holders For Mortality And Administration ChargesAssessedToContractHoldersForMortalityAndAdministration	66000000	usd
CY2023Q1	fg	Charges Assessed To Contract Holders For Mortality And Administration ChargesAssessedToContractHoldersForMortalityAndAdministration	58000000	usd
CY2024Q1	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	17000000	usd
CY2023Q1	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	19000000	usd
CY2024Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	7000000	usd
CY2023Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	5000000	usd
CY2024Q1	fg	Unrealized Gain Loss On Investment In Limited Partnerships UnrealizedGainLossOnInvestmentInLimitedPartnerships	49000000	usd
CY2023Q1	fg	Unrealized Gain Loss On Investment In Limited Partnerships UnrealizedGainLossOnInvestmentInLimitedPartnerships	57000000	usd
CY2024Q1	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	223000000	usd
CY2023Q1	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	166000000	usd
CY2024Q1	us-gaap	Increase Decrease In Reinsurance Recoverable IncreaseDecreaseInReinsuranceRecoverable	22000000	usd
CY2023Q1	us-gaap	Increase Decrease In Reinsurance Recoverable IncreaseDecreaseInReinsuranceRecoverable	0	usd
CY2024Q1	us-gaap	Increase Decrease In Future Policy Benefit Reserves IncreaseDecreaseInFuturePolicyBenefitReserves	505000000	usd
CY2023Q1	us-gaap	Increase Decrease In Future Policy Benefit Reserves IncreaseDecreaseInFuturePolicyBenefitReserves	224000000	usd
CY2024Q1	us-gaap	Increase Decrease In Reinsurance Payables IncreaseDecreaseInReinsurancePayables	940000000	usd
CY2023Q1	us-gaap	Increase Decrease In Reinsurance Payables IncreaseDecreaseInReinsurancePayables	1124000000	usd
CY2024Q1	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	20000000	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-13000000	usd
CY2024Q1	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	33000000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	-11000000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1534000000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1437000000	usd
CY2024Q1	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	1586000000	usd
CY2023Q1	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	915000000	usd
CY2024Q1	fg	Payments To Acquire Property Plantand Equipmentand Software PaymentsToAcquirePropertyPlantandEquipmentandSoftware	7000000	usd
CY2023Q1	fg	Payments To Acquire Property Plantand Equipmentand Software PaymentsToAcquirePropertyPlantandEquipmentandSoftware	6000000	usd
CY2024Q1	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	3636000000	usd
CY2023Q1	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	3900000000	usd
CY2024Q1	us-gaap	Payments For Proceeds From Short Term Investments PaymentsForProceedsFromShortTermInvestments	-1190000000	usd
CY2023Q1	us-gaap	Payments For Proceeds From Short Term Investments PaymentsForProceedsFromShortTermInvestments	-785000000	usd
CY2024Q1	fg	Payments For Proceeds From Other Acquisitions And Disposals Net Of Cash Acquired PaymentsForProceedsFromOtherAcquisitionsAndDisposalsNetOfCashAcquired	268000000	usd
CY2023Q1	fg	Payments For Proceeds From Other Acquisitions And Disposals Net Of Cash Acquired PaymentsForProceedsFromOtherAcquisitionsAndDisposalsNetOfCashAcquired	0	usd
CY2024Q1	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	266000000	usd
CY2023Q1	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	293000000	usd
CY2024Q1	us-gaap	Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital	17000000	usd
CY2023Q1	us-gaap	Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital	91000000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1384000000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2408000000	usd
CY2024Q1	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	0	usd
CY2023Q1	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	500000000	usd
CY2024Q1	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	5000000	usd
CY2023Q1	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	10000000	usd
CY2024Q1	us-gaap	Proceeds From Repayments Of Other Long Term Debt ProceedsFromRepaymentsOfOtherLongTermDebt	0	usd
CY2023Q1	us-gaap	Proceeds From Repayments Of Other Long Term Debt ProceedsFromRepaymentsOfOtherLongTermDebt	-35000000	usd
CY2024Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	26000000	usd
CY2023Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	25000000	usd
CY2024Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	6000000	usd
CY2023Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	usd
CY2024Q1	us-gaap	Proceeds From Issuance Of Convertible Preferred Stock ProceedsFromIssuanceOfConvertiblePreferredStock	250000000	usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Convertible Preferred Stock ProceedsFromIssuanceOfConvertiblePreferredStock	0	usd
CY2024Q1	us-gaap	Proceeds From Annuities And Investment Certificates ProceedsFromAnnuitiesAndInvestmentCertificates	1929000000	usd
CY2023Q1	us-gaap	Proceeds From Annuities And Investment Certificates ProceedsFromAnnuitiesAndInvestmentCertificates	2115000000	usd
CY2024Q1	us-gaap	Repayments Of Annuities And Investment Certificates RepaymentsOfAnnuitiesAndInvestmentCertificates	1483000000	usd
CY2023Q1	us-gaap	Repayments Of Annuities And Investment Certificates RepaymentsOfAnnuitiesAndInvestmentCertificates	950000000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	659000000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1595000000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	809000000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	624000000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1563000000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	960000000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2372000000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1584000000	usd
CY2024Q1	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1	insuranceagent
CY2024Q1	us-gaap	Reclassification From Aoci Current Period Tax ReclassificationFromAociCurrentPeriodTax	-4000000	usd
CY2023Q1	us-gaap	Reclassification From Aoci Current Period Tax ReclassificationFromAociCurrentPeriodTax	-11000000	usd
CY2024Q1	us-gaap	Equity Method Investments Fair Value Disclosure EquityMethodInvestmentsFairValueDisclosure	343000000	usd
CY2024Q1	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	1326000000	usd
CY2024Q1	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure	5161000000	usd
CY2023Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	1296000000	usd
CY2023Q4	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure	4661000000	usd
CY2024Q1	us-gaap	Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest Before Allowance For Credit Loss DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss	45792000000	usd
CY2024Q1	us-gaap	Debt Securities Available For Sale Amortized Cost Allowance For Credit Loss Excluding Accrued Interest DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest	33000000	usd
CY2024Q1	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	492000000	usd
CY2024Q1	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	3620000000	usd
CY2024Q1	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest DebtSecuritiesAvailableForSaleExcludingAccruedInterest	42631000000	usd
CY2023Q4	us-gaap	Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest Before Allowance For Credit Loss DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss	43601000000	usd
CY2023Q4	us-gaap	Debt Securities Available For Sale Amortized Cost Allowance For Credit Loss Excluding Accrued Interest DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest	35000000	usd
CY2023Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	444000000	usd
CY2023Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	3591000000	usd
CY2023Q4	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest DebtSecuritiesAvailableForSaleExcludingAccruedInterest	40419000000	usd
CY2024Q1	fg	Investment Non Income Producing Greater Than Twelve Months Fair Value Disclosure InvestmentNonIncomeProducingGreaterThanTwelveMonthsFairValueDisclosure	69000000	usd
CY2023Q4	fg	Investment Non Income Producing Greater Than Twelve Months Fair Value Disclosure InvestmentNonIncomeProducingGreaterThanTwelveMonthsFairValueDisclosure	47000000	usd
CY2024Q1	us-gaap	Debt Securities Available For Sale Accrued Interest After Allowance For Credit Loss DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss	512000000	usd
CY2023Q4	us-gaap	Debt Securities Available For Sale Accrued Interest After Allowance For Credit Loss DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss	469000000	usd
CY2024Q1	us-gaap	Federal Home Loan Bank Advances General Debt Obligations Disclosures Collateral Pledged1 FederalHomeLoanBankAdvancesGeneralDebtObligationsDisclosuresCollateralPledged1	4518000000	usd
CY2023Q4	us-gaap	Federal Home Loan Bank Advances General Debt Obligations Disclosures Collateral Pledged1 FederalHomeLoanBankAdvancesGeneralDebtObligationsDisclosuresCollateralPledged1	4345000000	usd
CY2024Q1	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	404000000	usd
CY2024Q1	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	393000000	usd
CY2023Q4	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	383000000	usd
CY2023Q4	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	374000000	usd
CY2024Q1	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost	3700000000	usd
CY2024Q1	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	3614000000	usd
CY2023Q4	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost	3207000000	usd
CY2023Q4	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	3129000000	usd
CY2024Q1	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost	3492000000	usd
CY2024Q1	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue	3333000000	usd
CY2023Q4	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost	2822000000	usd
CY2024Q1	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue	12966000000	usd
CY2023Q4	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost	15333000000	usd
CY2023Q4	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue	2680000000	usd
CY2024Q1	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost	15424000000	usd
CY2023Q4	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue	13068000000	usd
CY2024Q1	us-gaap	Available For Sale Securities Debt Maturities Single Maturity Date Amortized Cost Basis AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis	23020000000	usd
CY2024Q1	us-gaap	Available For Sale Securities Debt Maturities Single Maturity Date AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate	20306000000	usd
CY2023Q4	us-gaap	Available For Sale Securities Debt Maturities Single Maturity Date Amortized Cost Basis AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis	21745000000	usd
CY2023Q4	us-gaap	Available For Sale Securities Debt Maturities Single Maturity Date AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate	19251000000	usd
CY2024Q1	us-gaap	Available For Sale Securities Debt Maturities Without Single Maturity Date Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost	22772000000	usd
CY2024Q1	us-gaap	Available For Sale Securities Debt Maturities Without Single Maturity Date Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue	22325000000	usd
CY2023Q4	us-gaap	Available For Sale Securities Debt Maturities Without Single Maturity Date Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost	21856000000	usd
CY2023Q4	us-gaap	Available For Sale Securities Debt Maturities Without Single Maturity Date Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue	21168000000	usd
CY2024Q1	us-gaap	Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest Before Allowance For Credit Loss DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss	45792000000	usd
CY2024Q1	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest DebtSecuritiesAvailableForSaleExcludingAccruedInterest	42631000000	usd
CY2023Q4	us-gaap	Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest Before Allowance For Credit Loss DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss	43601000000	usd
CY2023Q4	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest DebtSecuritiesAvailableForSaleExcludingAccruedInterest	40419000000	usd
CY2023Q4	us-gaap	Debt Securities Available For Sale Amortized Cost Allowance For Credit Loss Excluding Accrued Interest DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest	35000000	usd
CY2024Q1	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest Allowance For Credit Loss Not Previously Recorded DebtSecuritiesAvailableForSaleExcludingAccruedInterestAllowanceForCreditLossNotPreviouslyRecorded	1000000	usd
CY2024Q1	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest Purchased With Credit Deterioration Allowance For Credit Loss At Acquisition Date DebtSecuritiesAvailableForSaleExcludingAccruedInterestPurchasedWithCreditDeteriorationAllowanceForCreditLossAtAcquisitionDate	0	usd
CY2024Q1	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest Allowance For Credit Loss Not To Sell Before Recovery Credit Loss Previously Recorded Expense Reversal DebtSecuritiesAvailableForSaleExcludingAccruedInterestAllowanceForCreditLossNotToSellBeforeRecoveryCreditLossPreviouslyRecordedExpenseReversal	-3000000	usd
CY2024Q1	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest Allowance For Credit Loss Securities Sold DebtSecuritiesAvailableForSaleExcludingAccruedInterestAllowanceForCreditLossSecuritiesSold	0	usd
CY2024Q1	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest Allowance For Credit Loss Sell Before Recovery DebtSecuritiesAvailableForSaleExcludingAccruedInterestAllowanceForCreditLossSellBeforeRecovery	0	usd
CY2024Q1	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest Allowance For Credit Loss Writeoff DebtSecuritiesAvailableForSaleExcludingAccruedInterestAllowanceForCreditLossWriteoff	0	usd
CY2024Q1	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest Allowance For Credit Loss Recovery DebtSecuritiesAvailableForSaleExcludingAccruedInterestAllowanceForCreditLossRecovery	0	usd
CY2024Q1	us-gaap	Debt Securities Available For Sale Amortized Cost Allowance For Credit Loss Excluding Accrued Interest DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest	33000000	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale Amortized Cost Allowance For Credit Loss Excluding Accrued Interest DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest	31000000	usd
CY2023Q1	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest Allowance For Credit Loss Not Previously Recorded DebtSecuritiesAvailableForSaleExcludingAccruedInterestAllowanceForCreditLossNotPreviouslyRecorded	7000000	usd
CY2023Q1	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest Purchased With Credit Deterioration Allowance For Credit Loss At Acquisition Date DebtSecuritiesAvailableForSaleExcludingAccruedInterestPurchasedWithCreditDeteriorationAllowanceForCreditLossAtAcquisitionDate	0	usd
CY2023Q1	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest Allowance For Credit Loss Not To Sell Before Recovery Credit Loss Previously Recorded Expense Reversal DebtSecuritiesAvailableForSaleExcludingAccruedInterestAllowanceForCreditLossNotToSellBeforeRecoveryCreditLossPreviouslyRecordedExpenseReversal	-7000000	usd
CY2023Q1	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest Allowance For Credit Loss Securities Sold DebtSecuritiesAvailableForSaleExcludingAccruedInterestAllowanceForCreditLossSecuritiesSold	15000000	usd
CY2023Q1	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest Allowance For Credit Loss Sell Before Recovery DebtSecuritiesAvailableForSaleExcludingAccruedInterestAllowanceForCreditLossSellBeforeRecovery	0	usd
CY2023Q1	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest Allowance For Credit Loss Writeoff DebtSecuritiesAvailableForSaleExcludingAccruedInterestAllowanceForCreditLossWriteoff	0	usd
CY2023Q1	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest Allowance For Credit Loss Recovery DebtSecuritiesAvailableForSaleExcludingAccruedInterestAllowanceForCreditLossRecovery	0	usd
CY2023Q1	us-gaap	Debt Securities Available For Sale Amortized Cost Allowance For Credit Loss Excluding Accrued Interest DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest	16000000	usd
CY2023Q1	us-gaap	Debt Securities Available For Sale Purchased With Credit Deterioration Amount At Purchase Price DebtSecuritiesAvailableForSalePurchasedWithCreditDeteriorationAmountAtPurchasePrice	0	usd
CY2024Q1	us-gaap	Debt Securities Available For Sale Purchased With Credit Deterioration Amount At Purchase Price DebtSecuritiesAvailableForSalePurchasedWithCreditDeteriorationAmountAtPurchasePrice	0	usd
CY2024Q1	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months	6474000000	usd
CY2024Q1	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	239000000	usd
CY2024Q1	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger	19000000000	usd
CY2024Q1	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	3334000000	usd
CY2024Q1	us-gaap	Debt Securities Available For Sale Unrealized Loss Position DebtSecuritiesAvailableForSaleUnrealizedLossPosition	25474000000	usd
CY2024Q1	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss	3573000000	usd
CY2024Q1	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Number Of Positions DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions	1213	security
CY2024Q1	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Number Of Positions DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions	2550	security
CY2024Q1	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Number Of Positions DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions	3763	security
CY2023Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months	5594000000	usd
CY2023Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	293000000	usd
CY2023Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger	19711000000	usd
CY2023Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	3242000000	usd
CY2023Q4	us-gaap	Debt Securities Available For Sale Unrealized Loss Position DebtSecuritiesAvailableForSaleUnrealizedLossPosition	25305000000	usd
CY2023Q4	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss	3535000000	usd
CY2023Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Number Of Positions DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions	927	security
CY2023Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Number Of Positions DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions	2602	security
CY2023Q4	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Number Of Positions DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions	3529	security
CY2024Q1	us-gaap	Debt Securities Available For Sale Amortized Cost Allowance For Credit Loss Excluding Accrued Interest DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest	33000000	usd
CY2024Q1	fg	Debt Securities Available For Sale Unrealized Loss Position Allowance For Credit Loss Excluding Accrued Interest DebtSecuritiesAvailableForSaleUnrealizedLossPositionAllowanceForCreditLossExcludingAccruedInterest	0	usd
CY2024Q1	us-gaap	Financing Receivable Excluding Accrued Interest Year One Originated Current Fiscal Year Writeoff FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYearWriteoff	0	usd
CY2024Q1	us-gaap	Financing Receivable Excluding Accrued Interest Year Two Originated Fiscal Year Before Current Fiscal Year Writeoff FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYearWriteoff	0	usd
CY2024Q1	us-gaap	Financing Receivable Excluding Accrued Interest Year Three Originated Two Years Before Current Fiscal Year Writeoff FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYearWriteoff	0	usd
CY2024Q1	us-gaap	Financing Receivable Excluding Accrued Interest Year Four Originated Three Years Before Current Fiscal Year Writeoff FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYearWriteoff	0	usd
CY2024Q1	us-gaap	Financing Receivable Excluding Accrued Interest Year Five Originated Four Years Before Current Fiscal Year Writeoff FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYearWriteoff	0	usd
CY2023Q1	us-gaap	Financing Receivable Excluding Accrued Interest Year One Originated Current Fiscal Year Writeoff FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYearWriteoff	0	usd
CY2023Q1	us-gaap	Financing Receivable Excluding Accrued Interest Year Two Originated Fiscal Year Before Current Fiscal Year Writeoff FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYearWriteoff	0	usd
CY2023Q1	us-gaap	Financing Receivable Excluding Accrued Interest Year Three Originated Two Years Before Current Fiscal Year Writeoff FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYearWriteoff	0	usd
CY2023Q1	us-gaap	Financing Receivable Excluding Accrued Interest Year Four Originated Three Years Before Current Fiscal Year Writeoff FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYearWriteoff	0	usd
CY2023Q1	us-gaap	Financing Receivable Excluding Accrued Interest Year Five Originated Four Years Before Current Fiscal Year Writeoff FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYearWriteoff	0	usd
CY2023Q4	fg	Loans Under Development Fair Value LoansUnderDevelopmentFairValue	22000000	usd
CY2023Q4	fg	Loans Under Development Amortized Cost LoansUnderDevelopmentAmortizedCost	22000000	usd
CY2024Q1	fg	Debt Service Coverage Ratio Amortization Period DebtServiceCoverageRatioAmortizationPeriod	P25Y
CY2023Q4	fg	Loans Under Development Amortized Cost LoansUnderDevelopmentAmortizedCost	22000000	usd
CY2023Q4	fg	Loans Under Development Fair Value LoansUnderDevelopmentFairValue	22000000	usd
CY2023Q4	fg	Loans Under Development Amortized Cost LoansUnderDevelopmentAmortizedCost	22000000	usd
CY2023Q4	fg	Loans Under Development Fair Value LoansUnderDevelopmentFairValue	22000000	usd
CY2024Q1	us-gaap	Financing Receivable Excluding Accrued Interest Nonaccrual FinancingReceivableExcludingAccruedInterestNonaccrual	66000000	usd
CY2023Q4	us-gaap	Financing Receivable Excluding Accrued Interest Nonaccrual FinancingReceivableExcludingAccruedInterestNonaccrual	57000000	usd
CY2024Q1	us-gaap	Financing Receivable Excluding Accrued Interest Nonaccrual FinancingReceivableExcludingAccruedInterestNonaccrual	66000000	usd
CY2023Q4	us-gaap	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest	66000000	usd
CY2024Q1	us-gaap	Financing Receivable Excluding Accrued Interest Credit Loss Expense Reversal FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal	1000000	usd
CY2024Q1	us-gaap	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest	67000000	usd
CY2022Q4	us-gaap	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest	42000000	usd
CY2023Q1	us-gaap	Financing Receivable Excluding Accrued Interest Credit Loss Expense Reversal FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal	18000000	usd
CY2023Q1	us-gaap	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest	60000000	usd
CY2024Q1	us-gaap	Gross Investment Income Operating GrossInvestmentIncomeOperating	686000000	usd
CY2023Q1	us-gaap	Gross Investment Income Operating GrossInvestmentIncomeOperating	580000000	usd
CY2024Q1	us-gaap	Investment Income Investment Expense InvestmentIncomeInvestmentExpense	70000000	usd
CY2023Q1	us-gaap	Investment Income Investment Expense InvestmentIncomeInvestmentExpense	61000000	usd
CY2024Q1	us-gaap	Net Investment Income NetInvestmentIncome	616000000	usd
CY2023Q1	us-gaap	Net Investment Income NetInvestmentIncome	519000000	usd
CY2024Q1	us-gaap	Debt Securities Realized Gain Loss DebtSecuritiesRealizedGainLoss	-19000000	usd
CY2023Q1	us-gaap	Debt Securities Realized Gain Loss DebtSecuritiesRealizedGainLoss	-44000000	usd
CY2024Q1	us-gaap	Gain Loss On Sale Of Other Investments GainLossOnSaleOfOtherInvestments	58000000	usd
CY2023Q1	us-gaap	Gain Loss On Sale Of Other Investments GainLossOnSaleOfOtherInvestments	0	usd
CY2024Q1	us-gaap	Financing Receivable Excluding Accrued Interest Allowance For Credit Loss Period Increase Decrease FinancingReceivableExcludingAccruedInterestAllowanceForCreditLossPeriodIncreaseDecrease	0	usd
CY2023Q1	us-gaap	Financing Receivable Excluding Accrued Interest Allowance For Credit Loss Period Increase Decrease FinancingReceivableExcludingAccruedInterestAllowanceForCreditLossPeriodIncreaseDecrease	-8000000	usd
CY2024Q1	us-gaap	Gain Loss On Sale Of Derivatives GainLossOnSaleOfDerivatives	21000000	usd
CY2023Q1	us-gaap	Gain Loss On Sale Of Derivatives GainLossOnSaleOfDerivatives	-89000000	usd
CY2024Q1	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	158000000	usd
CY2023Q1	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	147000000	usd
CY2024Q1	us-gaap	Embedded Derivative Gain Loss On Embedded Derivative Net EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet	3000000	usd
CY2023Q1	us-gaap	Embedded Derivative Gain Loss On Embedded Derivative Net EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet	2000000	usd
CY2024Q1	fg	Change In Fair Value Derivatives Including Other Derivatives ChangeInFairValueDerivativesIncludingOtherDerivatives	164000000	usd
CY2023Q1	fg	Change In Fair Value Derivatives Including Other Derivatives ChangeInFairValueDerivativesIncludingOtherDerivatives	41000000	usd
CY2024Q1	us-gaap	Gain Loss On Investments GainLossOnInvestments	212000000	usd
CY2023Q1	us-gaap	Gain Loss On Investments GainLossOnInvestments	-15000000	usd
CY2024Q1	fg	Reinsurance Agreement Recognized Gains Losses ReinsuranceAgreementRecognizedGainsLosses	-19000000	usd
CY2023Q1	fg	Reinsurance Agreement Recognized Gains Losses ReinsuranceAgreementRecognizedGainsLosses	-22000000	usd
CY2024Q1	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	578000000	usd
CY2023Q1	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	445000000	usd
CY2024Q1	us-gaap	Debt Securities Available For Sale Realized Gain DebtSecuritiesAvailableForSaleRealizedGain	8000000	usd
CY2023Q1	us-gaap	Debt Securities Available For Sale Realized Gain DebtSecuritiesAvailableForSaleRealizedGain	3000000	usd
CY2024Q1	us-gaap	Debt Securities Available For Sale Realized Loss DebtSecuritiesAvailableForSaleRealizedLoss	24000000	usd
CY2023Q1	us-gaap	Debt Securities Available For Sale Realized Loss DebtSecuritiesAvailableForSaleRealizedLoss	49000000	usd
CY2024Q1	fg	Investments Owned Vie Unconsolidated Carrying Value InvestmentsOwnedVIEUnconsolidatedCarryingValue	25358000000	usd
CY2024Q1	us-gaap	Variable Interest Entity Entity Maximum Loss Exposure Amount VariableInterestEntityEntityMaximumLossExposureAmount	29175000000	usd
CY2023Q4	fg	Investments Owned Vie Unconsolidated Carrying Value InvestmentsOwnedVIEUnconsolidatedCarryingValue	23908000000	usd
CY2023Q4	us-gaap	Variable Interest Entity Entity Maximum Loss Exposure Amount VariableInterestEntityEntityMaximumLossExposureAmount	27152000000	usd
CY2024Q1	us-gaap	Derivative Fair Value Of Derivative Asset DerivativeFairValueOfDerivativeAsset	1188000000	usd
CY2023Q4	us-gaap	Derivative Fair Value Of Derivative Asset DerivativeFairValueOfDerivativeAsset	977000000	usd
CY2024Q1	us-gaap	Derivative Fair Value Of Derivative Liability DerivativeFairValueOfDerivativeLiability	4698000000	usd
CY2023Q4	us-gaap	Derivative Fair Value Of Derivative Liability DerivativeFairValueOfDerivativeLiability	4258000000	usd
CY2024Q1	fg	Number Of Policies Reinsured By Foreign Company Not Engaged In Insurance NumberOfPoliciesReinsuredByForeignCompanyNotEngagedInInsurance	0	policy
CY2024Q1	us-gaap	Reinsurance Recoverables Gross ReinsuranceRecoverablesGross	10133000000	usd
CY2023Q4	us-gaap	Reinsurance Recoverables Gross ReinsuranceRecoverablesGross	8981000000	usd
CY2024Q1	us-gaap	Reinsurance Recoverables Allowance ReinsuranceRecoverablesAllowance	21000000	usd
CY2023Q4	us-gaap	Reinsurance Recoverables Allowance ReinsuranceRecoverablesAllowance	21000000	usd
CY2024Q1	us-gaap	Reinsurance Recoverables ReinsuranceRecoverables	10112000000	usd
CY2023Q4	us-gaap	Reinsurance Recoverables ReinsuranceRecoverables	8960000000	usd
CY2024Q1	fg	Reinsurance Retrocession Quota Share Basis Percentage ReinsuranceRetrocessionQuotaShareBasisPercentage	0.90
CY2023	fg	Reinsurance Retrocession Quota Share Basis Percentage ReinsuranceRetrocessionQuotaShareBasisPercentage	0.90
CY2024Q1	fg	Reinsurance Risk Charge Fee ReinsuranceRiskChargeFee	10000000	usd
CY2023Q1	fg	Reinsurance Risk Charge Fee ReinsuranceRiskChargeFee	10000000	usd
CY2023Q4	us-gaap	Reinsurance Recoverables Allowance ReinsuranceRecoverablesAllowance	21000000	usd
CY2022Q4	us-gaap	Reinsurance Recoverables Allowance ReinsuranceRecoverablesAllowance	10000000	usd
CY2024Q1	us-gaap	Reinsurance Recoverable Credit Loss Expense Reversal ReinsuranceRecoverableCreditLossExpenseReversal	0	usd
CY2023Q1	us-gaap	Reinsurance Recoverable Credit Loss Expense Reversal ReinsuranceRecoverableCreditLossExpenseReversal	-1000000	usd
CY2024Q1	us-gaap	Reinsurance Recoverables Allowance ReinsuranceRecoverablesAllowance	21000000	usd
CY2023Q1	us-gaap	Reinsurance Recoverables Allowance ReinsuranceRecoverablesAllowance	9000000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	473000000	usd
CY2024Q1	us-gaap	Value Of Business Acquired Voba ValueOfBusinessAcquiredVOBA	1407000000	usd
CY2023Q4	us-gaap	Value Of Business Acquired Voba ValueOfBusinessAcquiredVOBA	1446000000	usd
CY2024Q1	fg	Deferred Policy Acquisition Costs Including Funding Agreements DeferredPolicyAcquisitionCostsIncludingFundingAgreements	2412000000	usd
CY2023Q4	fg	Deferred Policy Acquisition Costs Including Funding Agreements DeferredPolicyAcquisitionCostsIncludingFundingAgreements	2215000000	usd
CY2024Q1	us-gaap	Deferred Sales Inducements Net DeferredSalesInducementsNet	392000000	usd
CY2023Q4	us-gaap	Deferred Sales Inducements Net DeferredSalesInducementsNet	346000000	usd
CY2024Q1	us-gaap	Other Intangible Assets Net OtherIntangibleAssetsNet	4612000000	usd
CY2023Q4	us-gaap	Other Intangible Assets Net OtherIntangibleAssetsNet	4207000000	usd
CY2023Q4	us-gaap	Value Of Business Acquired Voba ValueOfBusinessAcquiredVOBA	1446000000	usd
CY2024Q1	us-gaap	Present Value Of Future Insurance Profits Amortization Expense1 PresentValueOfFutureInsuranceProfitsAmortizationExpense1	39000000	usd
CY2024Q1	us-gaap	Value Of Business Acquired Voba ValueOfBusinessAcquiredVOBA	1407000000	usd
CY2022Q4	us-gaap	Value Of Business Acquired Voba ValueOfBusinessAcquiredVOBA	1615000000	usd
CY2023Q1	us-gaap	Present Value Of Future Insurance Profits Amortization Expense1 PresentValueOfFutureInsuranceProfitsAmortizationExpense1	43000000	usd
CY2023Q1	us-gaap	Value Of Business Acquired Voba ValueOfBusinessAcquiredVOBA	1572000000	usd
CY2024Q1	us-gaap	Present Value Of Future Insurance Profits Amortization Expense1 PresentValueOfFutureInsuranceProfitsAmortizationExpense1	39000000	usd
CY2023Q1	us-gaap	Present Value Of Future Insurance Profits Amortization Expense1 PresentValueOfFutureInsuranceProfitsAmortizationExpense1	43000000	usd
CY2023Q4	us-gaap	Deferred Policy Acquisition Costs DeferredPolicyAcquisitionCosts	2211000000	usd
CY2024Q1	us-gaap	Deferred Policy Acquisition Costs Additions DeferredPolicyAcquisitionCostsAdditions	257000000	usd
CY2024Q1	us-gaap	Deferred Policy Acquisition Cost Amortization Expense DeferredPolicyAcquisitionCostAmortizationExpense	60000000	usd
CY2024Q1	us-gaap	Deferred Policy Acquisition Costs DeferredPolicyAcquisitionCosts	2408000000	usd
CY2022Q4	us-gaap	Deferred Policy Acquisition Costs DeferredPolicyAcquisitionCosts	1402000000	usd
CY2023Q1	us-gaap	Deferred Policy Acquisition Costs Additions DeferredPolicyAcquisitionCostsAdditions	221000000	usd
CY2023Q1	us-gaap	Deferred Policy Acquisition Cost Amortization Expense DeferredPolicyAcquisitionCostAmortizationExpense	35000000	usd
CY2023Q1	fg	Deferred Policy Acquisition Cost Reinsurance Related Adjustments DeferredPolicyAcquisitionCostReinsuranceRelatedAdjustments	79000000	usd
CY2023Q1	us-gaap	Deferred Policy Acquisition Costs DeferredPolicyAcquisitionCosts	1667000000	usd
CY2023Q1	fg	Effective Income Tax Rate Continuing Operations Before Equity In Earnings Losses Of Unconsolidated Subsidiary EffectiveIncomeTaxRateContinuingOperationsBeforeEquityInEarningsLossesOfUnconsolidatedSubsidiary	0.04
CY2024Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	86000000	usd
CY2024Q1	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	431000000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	85000000	usd
CY2024Q1	us-gaap	Deferred Policy Acquisition Cost Amortization Expense DeferredPolicyAcquisitionCostAmortizationExpense	60000000	usd
CY2023Q1	us-gaap	Deferred Policy Acquisition Cost Amortization Expense DeferredPolicyAcquisitionCostAmortizationExpense	35000000	usd
CY2024Q1	fg	Deferred Policy Acquisition Costs Including Funding Agreements DeferredPolicyAcquisitionCostsIncludingFundingAgreements	2412000000	usd
CY2023Q4	fg	Deferred Policy Acquisition Costs Including Funding Agreements DeferredPolicyAcquisitionCostsIncludingFundingAgreements	2215000000	usd
CY2023Q1	us-gaap	Deferred Sales Inducements Net DeferredSalesInducementsNet	225000000	usd
CY2024Q1	us-gaap	Present Value Of Future Insurance Profits Amortization Expense Remainder Of Fiscal Year PresentValueOfFutureInsuranceProfitsAmortizationExpenseRemainderOfFiscalYear	111000000	usd
CY2024Q1	us-gaap	Present Value Of Future Insurance Profits Amortization Expense Year One PresentValueOfFutureInsuranceProfitsAmortizationExpenseYearOne	138000000	usd
CY2024Q1	us-gaap	Present Value Of Future Insurance Profits Amortization Expense Year Two PresentValueOfFutureInsuranceProfitsAmortizationExpenseYearTwo	126000000	usd
CY2024Q1	us-gaap	Present Value Of Future Insurance Profits Amortization Expense Year Three PresentValueOfFutureInsuranceProfitsAmortizationExpenseYearThree	115000000	usd
CY2024Q1	us-gaap	Present Value Of Future Insurance Profits Amortization Expense Year Four PresentValueOfFutureInsuranceProfitsAmortizationExpenseYearFour	105000000	usd
CY2024Q1	fg	Present Value Of Future Insurance Profits Expected Amortization After Year Four PresentValueOfFutureInsuranceProfitsExpectedAmortizationAfterYearFour	812000000	usd
CY2024Q1	us-gaap	Value Of Business Acquired Voba ValueOfBusinessAcquiredVOBA	1407000000	usd
CY2024Q1	us-gaap	Market Risk Benefit Asset Amount MarketRiskBenefitAssetAmount	95000000	usd
CY2024Q1	us-gaap	Market Risk Benefit Liability Amount MarketRiskBenefitLiabilityAmount	425000000	usd
CY2024Q1	us-gaap	Market Risk Benefit After Increase Decrease From Instrument Specific Credit Risk MarketRiskBenefitAfterIncreaseDecreaseFromInstrumentSpecificCreditRisk	330000000	usd
CY2023Q4	us-gaap	Market Risk Benefit Asset Amount MarketRiskBenefitAssetAmount	88000000	usd
CY2023Q4	us-gaap	Market Risk Benefit Liability Amount MarketRiskBenefitLiabilityAmount	403000000	usd
CY2023Q4	us-gaap	Market Risk Benefit After Increase Decrease From Instrument Specific Credit Risk MarketRiskBenefitAfterIncreaseDecreaseFromInstrumentSpecificCreditRisk	315000000	usd
CY2024Q1	fg	Effective Income Tax Rate Continuing Operations Before Equity In Earnings Losses Of Unconsolidated Subsidiary EffectiveIncomeTaxRateContinuingOperationsBeforeEquityInEarningsLossesOfUnconsolidatedSubsidiary	0.18
CY2024Q1	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	1000000	usd
CY2024Q1	us-gaap	Affordable Housing Tax Credits And Other Tax Benefits Amount AffordableHousingTaxCreditsAndOtherTaxBenefitsAmount	8000000	usd
CY2023Q1	us-gaap	Affordable Housing Tax Credits And Other Tax Benefits Amount AffordableHousingTaxCreditsAndOtherTaxBenefitsAmount	6000000	usd
CY2024Q1	us-gaap	Amortization Method Qualified Affordable Housing Project Investments Amortization AmortizationMethodQualifiedAffordableHousingProjectInvestmentsAmortization	6000000	usd
CY2023Q1	us-gaap	Amortization Method Qualified Affordable Housing Project Investments Amortization AmortizationMethodQualifiedAffordableHousingProjectInvestmentsAmortization	5000000	usd
CY2024Q1	us-gaap	Income Loss From Affordable Housing Projects Equity Method Investments IncomeLossFromAffordableHousingProjectsEquityMethodInvestments	2000000	usd
CY2023Q1	us-gaap	Income Loss From Affordable Housing Projects Equity Method Investments IncomeLossFromAffordableHousingProjectsEquityMethodInvestments	1000000	usd
CY2024Q1	us-gaap	Amortization Method Qualified Affordable Housing Project Investments AmortizationMethodQualifiedAffordableHousingProjectInvestments	120000000	usd
CY2023Q4	us-gaap	Amortization Method Qualified Affordable Housing Project Investments AmortizationMethodQualifiedAffordableHousingProjectInvestments	108000000	usd
CY2024Q1	fg	Policy Holder Account Balance Gross Liability PolicyHolderAccountBalanceGrossLiability	50875000000	usd
CY2023Q4	fg	Policy Holder Account Balance Gross Liability PolicyHolderAccountBalanceGrossLiability	48798000000	usd
CY2024Q1	fg	Policyholder Benefits And Claims Incurred Net Life And Annuity Change In Policy Reserves Increase Decrease PolicyholderBenefitsAndClaimsIncurredNetLifeAndAnnuityChangeInPolicyReservesIncreaseDecrease	57000000	usd
CY2024Q1	us-gaap	Liability For Future Policy Benefits LiabilityForFuturePolicyBenefits	7441000000	usd
CY2023Q4	us-gaap	Liability For Future Policy Benefits LiabilityForFuturePolicyBenefits	7050000000	usd
CY2024Q1	us-gaap	Liability For Future Policy Benefit Gross Premium Income LiabilityForFuturePolicyBenefitGrossPremiumIncome	620000000	usd
CY2023Q1	us-gaap	Liability For Future Policy Benefit Gross Premium Income LiabilityForFuturePolicyBenefitGrossPremiumIncome	301000000	usd
CY2024Q1	us-gaap	Liability For Future Policy Benefit Interest Expense LiabilityForFuturePolicyBenefitInterestExpense	73000000	usd
CY2023Q1	us-gaap	Liability For Future Policy Benefit Interest Expense LiabilityForFuturePolicyBenefitInterestExpense	48000000	usd
CY2024Q1	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	301000000	usd
CY2023Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	270000000	usd
CY2024Q1	us-gaap	Accrued Salaries Current And Noncurrent AccruedSalariesCurrentAndNoncurrent	48000000	usd
CY2023Q4	us-gaap	Accrued Salaries Current And Noncurrent AccruedSalariesCurrentAndNoncurrent	99000000	usd
CY2024Q1	us-gaap	Accrued Employee Benefits Current And Noncurrent AccruedEmployeeBenefitsCurrentAndNoncurrent	65000000	usd
CY2023Q4	us-gaap	Accrued Employee Benefits Current And Noncurrent AccruedEmployeeBenefitsCurrentAndNoncurrent	60000000	usd
CY2024Q1	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	301000000	usd
CY2023Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	270000000	usd
CY2024Q1	us-gaap	Accounts Payable Trade Current And Noncurrent AccountsPayableTradeCurrentAndNoncurrent	176000000	usd
CY2023Q4	us-gaap	Accounts Payable Trade Current And Noncurrent AccountsPayableTradeCurrentAndNoncurrent	297000000	usd
CY2024Q1	fg	Liability For Policy And Contract Claims LiabilityForPolicyAndContractClaims	93000000	usd
CY2023Q4	fg	Liability For Policy And Contract Claims LiabilityForPolicyAndContractClaims	92000000	usd
CY2024Q1	fg	Retained Asset Account RetainedAssetAccount	74000000	usd
CY2023Q4	fg	Retained Asset Account RetainedAssetAccount	81000000	usd
CY2024Q1	fg	Remittances And Items Not Allocated RemittancesAndItemsNotAllocated	236000000	usd
CY2023Q4	fg	Remittances And Items Not Allocated RemittancesAndItemsNotAllocated	284000000	usd
CY2024Q1	fg	Derivative Futures Liability DerivativeFuturesLiability	740000000	usd
CY2023Q4	fg	Derivative Futures Liability DerivativeFuturesLiability	588000000	usd
CY2024Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	11000000	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	11000000	usd
CY2024Q1	us-gaap	Payable Investment Purchase PayableInvestmentPurchase	193000000	usd
CY2023Q4	us-gaap	Payable Investment Purchase PayableInvestmentPurchase	21000000	usd
CY2024Q1	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	57000000	usd
CY2023Q4	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	0	usd
CY2024Q1	fg	Accrued Liability Derivative Mark To Market AccruedLiabilityDerivativeMarkToMarket	19000000	usd
CY2023Q4	fg	Accrued Liability Derivative Mark To Market AccruedLiabilityDerivativeMarkToMarket	0	usd
CY2024Q1	us-gaap	Other Accrued Liabilities Current And Noncurrent OtherAccruedLiabilitiesCurrentAndNoncurrent	224000000	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current And Noncurrent OtherAccruedLiabilitiesCurrentAndNoncurrent	208000000	usd
CY2024Q1	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	2237000000	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	2011000000	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	116000000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-195000000	usd
CY2024Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	1000000	usd
CY2023Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	0	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	115000000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-195000000	usd
CY2024Q1	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	4000000	usd
CY2024Q1	us-gaap	Long Term Debt LongTermDebt	1748000000	usd
CY2023Q4	us-gaap	Long Term Debt LongTermDebt	1754000000	usd
CY2024Q1	us-gaap	Interest Expense Debt InterestExpenseDebt	30000000	usd
CY2023Q1	us-gaap	Interest Expense Debt InterestExpenseDebt	22000000	usd
CY2024Q1	us-gaap	Interest Paid Net InterestPaidNet	32000000	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	9000000	usd
CY2024Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	1000000	usd
CY2023Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
CY2024Q1	fg	Deferred Sales Inducements Paid DeferredSalesInducementsPaid	54000000	usd
CY2023Q1	fg	Deferred Sales Inducements Paid DeferredSalesInducementsPaid	29000000	usd
CY2024Q1	fg	Noncash Investingand Financing Activities Changein Proceedsof Salesof Investments NoncashInvestingandFinancingActivitiesChangeinProceedsofSalesofInvestments	23000000	usd
CY2023Q1	fg	Noncash Investingand Financing Activities Changein Proceedsof Salesof Investments NoncashInvestingandFinancingActivitiesChangeinProceedsofSalesofInvestments	-22000000	usd
CY2024Q1	fg	Noncash Investingand Financing Activities Changein Purchasesof Investments NoncashInvestingandFinancingActivitiesChangeinPurchasesofInvestments	171000000	usd
CY2023Q1	fg	Noncash Investingand Financing Activities Changein Purchasesof Investments NoncashInvestingandFinancingActivitiesChangeinPurchasesofInvestments	79000000	usd
CY2023Q1	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	0	usd
CY2024Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	111000000	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-195000000	usd
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	124000000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	125000000	shares
CY2024Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	1000000	shares
CY2024Q1	us-gaap	Incremental Common Shares Attributable To Conversion Of Preferred Stock IncrementalCommonSharesAttributableToConversionOfPreferredStock	5000000	shares
CY2023Q1	us-gaap	Incremental Common Shares Attributable To Conversion Of Preferred Stock IncrementalCommonSharesAttributableToConversionOfPreferredStock	0	shares
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	130000000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	125000000	shares
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.90
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.56
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.88
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.56
CY2024Q1	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q1	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q1	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024Q1	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false

Files In Submission

Name	View Source	Status
0001934850-24-000027-index-headers.html	Edgar Link	pending
0001934850-24-000027-index.html	Edgar Link	pending
0001934850-24-000027.txt	Edgar Link	pending
0001934850-24-000027-xbrl.zip	Edgar Link	pending
exhibit311sarbanesoxleycer.htm	Edgar Link	pending
exhibit312sarbanesoxleycer.htm	Edgar Link	pending
exhibit321sarbanesoxleycer.htm	Edgar Link	pending
exhibit322sarbanesoxleycer.htm	Edgar Link	pending
fg-20240331.htm	Edgar Link	pending
fg-20240331.xsd	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R100.htm	Edgar Link	pending
R101.htm	Edgar Link	pending
R102.htm	Edgar Link	pending
R103.htm	Edgar Link	pending
R104.htm	Edgar Link	pending
R105.htm	Edgar Link	pending
R106.htm	Edgar Link	pending
R107.htm	Edgar Link	pending
R108.htm	Edgar Link	pending
R109.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R110.htm	Edgar Link	pending
R111.htm	Edgar Link	pending
R112.htm	Edgar Link	pending
R113.htm	Edgar Link	pending
R114.htm	Edgar Link	pending
R115.htm	Edgar Link	pending
R116.htm	Edgar Link	pending
R117.htm	Edgar Link	pending
R118.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
fg-20240331_def.xml	Edgar Link	unprocessable
fg-20240331_lab.xml	Edgar Link	unprocessable
fg-20240331_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
fg-20240331_htm.xml	Edgar Link	completed
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
R97.htm	Edgar Link	pending
R98.htm	Edgar Link	pending
R99.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
fg-20240331_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$FG
F&G Annuities & Life, Inc. Stock $fg

2024 Q2 Form 10-Q Financial Statement

#000193485024000027 Filed on May 10, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$FG F&G Annuities & Life, Inc. Stock $fg

2024 Q2 Form 10-Q Financial Statement

#000193485024000027 Filed on May 10, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$FG
F&G Annuities & Life, Inc. Stock $fg